Zachs also shows 2 BUY recommendation. Those reports are dated 10/4.
The one out today, 10/5, is from ValueEngine. It has $EARS as a strong sell based on it's proprietary ranking system which puts $EARS against other biotechs. In that system, biotechs with revenues are going to smash $EARS, and that's exactly why it's listed as a strong sell. Oddly, the report lists 1 STRONG BUY recommendation. Wish they showed the names of the firms.
Anyway, nice to see any coverage of $EARS at all. No one was covering for a long while.
Know What You Own. My posts should not be construed as investment advice.
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM